PE20080558A1 - Inhibidores no nucleosidos de la transcriptasa inversa - Google Patents

Inhibidores no nucleosidos de la transcriptasa inversa

Info

Publication number
PE20080558A1
PE20080558A1 PE2007000940A PE2007000940A PE20080558A1 PE 20080558 A1 PE20080558 A1 PE 20080558A1 PE 2007000940 A PE2007000940 A PE 2007000940A PE 2007000940 A PE2007000940 A PE 2007000940A PE 20080558 A1 PE20080558 A1 PE 20080558A1
Authority
PE
Peru
Prior art keywords
chloro
phenoxy
cyane
alkyl
fluor
Prior art date
Application number
PE2007000940A
Other languages
English (en)
Inventor
Zachary Kevin Sweeney
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20080558A1 publication Critical patent/PE20080558A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

REFERIDA A UN DERIVADO DE AMIDA DE FORMULA (I), DONDE R1 ES FLUOR O HIDROGENO; R2 ES H, CLORO, ALQUILO C1-C3, CICLOALQUILO C3-C5, ALCOXI C1-C3, BROMO; X1 ES O O S; X2 ES CLORO, CIANO, HALOALQUILO C1-C3, ENTRE OTROS; R3 ES ALQUILO C1-C6, HALOALQUILO C1-C3, ALCOXI C1-C6, ENTRE OTROS; R4 ES SONHR5aR6a, COX4, IMIDAZOLIDINDIONA, ENTRE OTROS; X4 ES OH O NR5NR6b; R5a Y R6a SON H, ALQUILO C1-C6, ENTRE OTROS; R5b Y R6b SON H, ALQUILO C1-C6, HIDROXIALQUILO C1-C6, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 2-[4-CLORO-3-(3-CLORO-5-CIANO-FENOXI)-2-FLUOR-FENOXI]-N-(2-CLORO-4-SULFAMOIL-FENIL)-ACETAMIDA, 2-[4-CLORO-3-(3-CLORO-5-CIANO-FENOXI)-2-FLUOR-FENOXI]-N-(2-METIL-4-SULFAMOIL-FENIL)-ACETAMIDA, N-(2-BROMO-4-SULFAMOIL-FENIL)-2-[4-CLORO-3-(3-CLORO-5-CIANO-FENOXI)-2-FLUOR-FENOXI]-ACETAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN PROCESO DE PREPARACION. DICHOS COMPUESTOS INHIBEN LA TRANSCRIPTASA INVERSA DEL VIH
PE2007000940A 2006-07-21 2007-07-19 Inhibidores no nucleosidos de la transcriptasa inversa PE20080558A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83248206P 2006-07-21 2006-07-21

Publications (1)

Publication Number Publication Date
PE20080558A1 true PE20080558A1 (es) 2008-05-16

Family

ID=38521766

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000940A PE20080558A1 (es) 2006-07-21 2007-07-19 Inhibidores no nucleosidos de la transcriptasa inversa

Country Status (16)

Country Link
US (1) US20080020981A1 (es)
EP (1) EP2046731A1 (es)
JP (1) JP2009544645A (es)
KR (1) KR20090031584A (es)
CN (1) CN101484418A (es)
AR (1) AR061943A1 (es)
AU (1) AU2007276180A1 (es)
BR (1) BRPI0714509A2 (es)
CA (1) CA2657723A1 (es)
CL (1) CL2007002105A1 (es)
IL (1) IL196144A0 (es)
MX (1) MX2009000574A (es)
PE (1) PE20080558A1 (es)
TW (1) TW200812942A (es)
WO (1) WO2008009613A1 (es)
ZA (1) ZA200900071B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009515826A (ja) * 2005-10-19 2009-04-16 エフ．ホフマン−ラ ロシュ アーゲー フェニル−アセトアミドｎｎｒｔ阻害剤
CN101784529A (zh) * 2007-06-22 2010-07-21 弗·哈夫曼-拉罗切有限公司 作为非核苷逆转录酶抑制剂的脲和氨基甲酸酯衍生物
CN102229547A (zh) * 2011-04-20 2011-11-02 复旦大学 一种萘苯醚类苯磺酰胺衍生物及其制备方法和用途
CN102206177A (zh) * 2011-04-20 2011-10-05 复旦大学 1-萘基苯甲酮衍生物及其制备方法和用途
JP7073272B2 (ja) * 2016-05-12 2022-05-23 リサーチ トライアングル インスティテュート 神経伝達物質放出剤としてのビニローグフェネチルアミン

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2405148B (en) * 2002-05-07 2006-08-23 Akzo Nobel Nv Neopentyl glycol bis(diaryl phosphate) esters
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
TW200505441A (en) * 2003-03-24 2005-02-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitorsⅠ
JP4485520B2 (ja) * 2003-03-24 2010-06-23 エフ．ホフマン−ラ ロシュ アーゲー 逆転写酵素阻害剤としてのベンジル−ピリダジノン類
US7220772B2 (en) * 2003-09-05 2007-05-22 Pfizer, Inc. Pyrazole derivatives
JP4627315B2 (ja) * 2004-03-23 2011-02-09 エフ．ホフマン−ラ ロシュ アーゲー 非ヌクレオシド逆転写酵素阻害剤としてのベンジルピリダジノン誘導体
US7625949B2 (en) * 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
BRPI0513858B8 (pt) * 2004-07-27 2021-05-25 Hoffmann La Roche compostos de benziltriazolona como inibidores não-nucleosídeos da transcriptase reversa, seu processo de preparação, seu uso e composição farmacêutica que os compreende
EP1797062B8 (en) * 2004-09-30 2011-05-25 Boehringer Ingelheim International GmbH Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors
EP1831157A2 (en) * 2004-12-22 2007-09-12 Pfizer Limited Nonnucleoside inhibitors of hiv-1 reverse transcriptase
JP2008534456A (ja) * 2005-03-24 2008-08-28 エフ．ホフマン−ラ ロシュ アーゲー ヘテロ環式逆転写酵素インヒビターとしての１，２，４−トリアゾール−５−オン化合物
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
CA2623728A1 (en) * 2005-09-30 2007-04-12 F. Hoffmann-La Roche Ag Nnrt inhibitors
JP2009515826A (ja) * 2005-10-19 2009-04-16 エフ．ホフマン−ラ ロシュ アーゲー フェニル−アセトアミドｎｎｒｔ阻害剤
EP1940782B1 (en) * 2005-10-19 2009-03-11 F.Hoffmann-La Roche Ag N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
KR20090031584A (ko) 2009-03-26
MX2009000574A (es) 2009-01-27
IL196144A0 (en) 2009-09-22
CL2007002105A1 (es) 2008-02-22
CA2657723A1 (en) 2008-01-24
WO2008009613A1 (en) 2008-01-24
CN101484418A (zh) 2009-07-15
JP2009544645A (ja) 2009-12-17
AU2007276180A1 (en) 2008-01-24
ZA200900071B (en) 2010-01-27
TW200812942A (en) 2008-03-16
AR061943A1 (es) 2008-10-01
EP2046731A1 (en) 2009-04-15
BRPI0714509A2 (pt) 2014-04-08
US20080020981A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
PE20080558A1 (es) Inhibidores no nucleosidos de la transcriptasa inversa
AR079015A1 (es) Acidos 3-fenilpropionicos sustituidos, metodo de preparacion y uso de los mismos
PE20011184A1 (es) Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa
PE20061065A1 (es) Derivados de piridazina como agentes inhibidores de esteaoril-coa desaturasa
ES2564782T3 (es) Compuestos derivados de 1-aril-5-alquil pirazol, procedimientos de fabricación y procedimientos de utilización de los mismos
PE20050013A1 (es) Composiciones farmaceuticas como inhibidores de la proteasa del virus de la hepatitis c
PE20070135A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasas
PE20021005A1 (es) Quinazolinas como inhibidores de mmp-13
CR7865A (es) Derivados de dihidropiranoindol -3,4-diona sustituidos y derivados de 2-hidroximetilindol del acido 3-oxoacetico sustituidos como inhibidores del inhibidor del activador del plasminogeno 1(pai-1)
PE20081448A1 (es) Inhibidores de transcriptasa inversa no nucleosidicos
RU2009102502A (ru) Способ превращения первичных амидоспиртов в амидокарбоновые кислоты с высоким выходом, используя воду в качестве растворителя
RS53061B (en) INHIBITORI PROTEIN KINAZE
PE20120403A1 (es) Aril-piridinas como inhibidoras de sintasa de aldosterona
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20120062A1 (es) Derivados de 1-bencil-2-amino-tetralina como inhibidores del transportador de glicina glyt1
PE20040087A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
RS51780B (en) INDASOLS SUBSTITUTED BY AMIDE AS INHIBITORS OF POLY (ADP-Ribose) POLYMERASES (PARP)
PE20110838A1 (es) Amidas del acido antranilico sustituidas con tetrazol como plaguicidas
CO6140060A2 (es) Derivados de aminocicloalquil 1,2,4-triazol como moduladores de mglur5
PE20060999A1 (es) Composiciones farmaceuticas que contienen un diuretico y un bloqueador del receptor de angiotensina ii
PE20070138A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasas
AR076274A1 (es) Inhibidores del virus de la hepatitis c
PE20121157A1 (es) Compuestos heterociclicos como inhibidores de proteasas serinas
PE20040592A1 (es) Antagonistas de cgrp elegidos, procedimiento para su preparacion
PE20020855A1 (es) Derivados de piperazina azaindoloxoacetico sustituidos con actividad antiviral

Legal Events

Date Code Title Description
FD Application declared void or lapsed